Literature DB >> 20627800

Regulation of immune cell homeostasis by type I interferons.

Fabrizio Mattei1, Giovanna Schiavoni, David F Tough.   

Abstract

Although initially identified and best characterized for their role in innate antiviral defence, type I interferons (IFN-I) are also known to have an important impact on the adaptive immune response. In part, this is linked to another long-recognised property of IFN-I, namely their ability to modify cellular proliferation and survival. Here, we review the influence of IFN-I on immune cell homeostasis, focusing on their effects on T cells and antigen-presenting cells.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20627800     DOI: 10.1016/j.cytogfr.2010.05.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  23 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.

Authors:  Kathrin Kastenmüller; Ulrike Wille-Reece; Ross W B Lindsay; Lauren R Trager; Patricia A Darrah; Barbara J Flynn; Maria R Becker; Mark C Udey; Björn E Clausen; Botond Z Igyarto; Daniel H Kaplan; Wolfgang Kastenmüller; Ronald N Germain; Robert A Seder
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

3.  Macrophage heterogeneity in lymphoid tissues.

Authors:  Joke M M den Haan; Luisa Martinez-Pomares
Journal:  Semin Immunopathol       Date:  2013-04-12       Impact factor: 9.623

Review 4.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

5.  Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.

Authors:  Steve P Crampton; Jonathan A Deane; Lionel Feigenbaum; Silvia Bolland
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

6.  Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.

Authors:  Daniel H Lachance; Ping Yang; Derek R Johnson; Paul A Decker; Thomas M Kollmeyer; Lucie S McCoy; Terri Rice; Yuanyuan Xiao; Francis Ali-Osman; Frances Wang; Shawn M Stoddard; Debra J Sprau; Matthew L Kosel; John K Wiencke; Joseph L Wiemels; Joseph S Patoka; Faith Davis; Bridget McCarthy; Amanda L Rynearson; Joel B Worra; Brooke L Fridley; Brian Patrick O'Neill; Jan C Buckner; Dora Il'yasova; Robert B Jenkins; Margaret R Wrensch
Journal:  Am J Epidemiol       Date:  2011-07-08       Impact factor: 4.897

7.  NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

Authors:  Joanna Jaworska; François Coulombe; Jeffrey Downey; Fanny Tzelepis; Karim Shalaby; Ivan Tattoli; Julie Berube; Simon Rousseau; James G Martin; Stephen E Girardin; Jonathan A McCullers; Maziar Divangahi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

Review 8.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

9.  Herpes Simplex Virus 1 Interaction with Myeloid Cells In Vivo.

Authors:  Maitreyi Shivkumar; Clara Lawler; Ricardo Milho; Philip G Stevenson
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases.

Authors:  Emilie Chauveau; Virginie Doceul; Estelle Lara; Micheline Adam; Emmanuel Breard; Corinne Sailleau; Cyril Viarouge; Alexandra Desprat; Gilles Meyer; Isabelle Schwartz-Cornil; Suzana Ruscanu; Bernard Charley; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.